Methylation-related genes and prognosis in non-small cell lung cancer
Author Information
Author(s): J Xing, D J Stewart, J Gu, C Lu, M R Spitz, X Wu
Primary Institution: The University of Texas MD Anderson Cancer Center
Hypothesis
The expression levels of methylation-related genes are associated with overall survival in patients with non-small cell lung cancer.
Conclusion
High levels of DNMT1 expression are linked to an increased risk of death in NSCLC patients, while DNMT3b and MBD2 have varying effects based on age and sex.
Supporting Evidence
- High DNMT1 expression is associated with a 74% increased risk of death.
- DNMT3b expression is linked to poor prognosis in patients under 65 years.
- MBD2 expression shows a protective effect in male and SQLC patients.
Takeaway
This study found that certain genes related to DNA methylation can help predict how long patients with lung cancer might live.
Methodology
The study measured mRNA expression levels of DNMT1, DNMT3b, and MBD2 in tumor samples using quantitative real-time PCR.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the specific patient population.
Limitations
The sample size in each stratum was small, and empirical cutoff points were chosen for gene expression.
Participant Demographics
The mean age of participants was 65 years, with 94% being white and 92% ever smokers.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI, 1.04–2.90
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website